PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 26, 2026Frontiers in Cellular and Infection Microbiology0 citationsOpen Access

Correlation between MIC of econazole nitrate and clinical response in otomycosis

YSYanwen SunDLD. Liu

Key Points

  • The study aims to evaluate the distribution of pathogenic fungi in otomycosis and investigate the correlation between drug susceptibility and clinical treatment duration.
  • Collected ear secretion specimens from 196 patients with otomycosis at Zhejiang Provincial Hospital.
  • Performed isolation, culture, identification of pathogens, and drug sensitivity testing.
  • Analyzed clinical data from 149 patients to assess the correlation between MIC and treatment duration.
  • Aspergillus species accounted for 85.10% of cases, with A. terreus being the most prevalent at 68.88%.
  • Significant interspecies differences in MIC of econazole nitrate were observed (P < 0.05).
  • A positive correlation was found between the clinical course duration and MIC in patients with A. terreus (0.2-12.5 μg/mL) and A. niger (0.59-37.5 μg/mL).

Abstract

Introduction Otomycosis is a common superficial fungal infection in otolaryngology, with an increasing incidence that severely affects patients’ quality of life. There are regional variations in the distribution of dominant pathogenic fungi. This study was designed to determine the distribution of pathogenic fungi causing otomycosis in the local region, evaluate the in vitro susceptibility of predominant strains to econazole nitrate (a commonly used antifungal agent), and preliminarily investigate the correlation between drug susceptibility and clinical treatment duration, so as to fill the gap in regional research in this field. Methods Ear secretion specimens from 196 patients with otomycosis were collected at the Department of Otolaryngology of Zhejiang Provincial Hospital of Chinese Medicine from December 2022 to December 2024 for isolation, culture, and identification of pathogens, along with drug sensitivity testing. Clinical data from 149 patients with complete follow-up records were combined to analyze the correlation between MIC and treatment duration. Results Among the 196 patients, Aspergillus was the predominant pathogen, accounting for 85.10% of which Aspergillus terreus ( A. terreus ) was the dominant species, accounting for 68.88%. Significant interspecies differences in MIC of econazole nitrate were observed among different Aspergillus strains (P 0.05). The clinical course in patients infected with A. terreus (3–90 days) and Aspergillus niger ( A. niger ) (7–60 days) was significantly positively correlated with their corresponding MIC (0.2-12.5 μg/mL and 0.59-37.5 μg/mL, respectively). Conclusion The pathogenic spectrum of otomycosis in this region is unique, with A. terreus as the main pathogen. There are interspecies differences in the in vitro sensitivity of Aspergillus to econazole nitrate, and the elevated MIC values were significantly associated with prolonged time to clinical improvement in patients infected with A. terreus and A. niger .

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Sun et al. (2026) studied this question.

synapsesocial.com/papers/6a153790b5d9c58d83e8bf3dhttps://doi.org/10.3389/fcimb.2026.1820764
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Dermal Formulation Incorporating Isoconazole Nitrate Nanoparticles Offers High Absorption into Skin and Antimicrobial Effect Against Candida albicans2025 · 1 citations
  2. 2Epidemiological characteristics and trends in the diagnosis and treatment of fungal otitis externa in children2025 · 2 citations
  3. 3Otomycosis; clinical features, predisposing factors and treatment implications2014 · 106 citations
  4. 4Comparison of the recovery rate of otomycosis using betadine and clotrimazole topical treatment2017 · 47 citations
  5. 5A Case of Topical Ofloxacin-Induced Otomycosis and Literature Review2021 · 10 citations